EUVIMEDEUVIMED entdecken
Open Access

Inhibition and Structure of Toxoplasma gondii Purine Nucleoside Phosphorylase

Teraya M Donaldson, María B Cassera, Meng-Chiao Ho, Chenyang Zhan, Emilio F Merino, Gary B Evans, Peter C Tyler, Steven C Almo, Vern L Schramm, Kami Kim

Eukaryotic Cell · 2014-05 · 13 (5) · 572-579

DOI: 10.1128/ec.00308-13 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eukaryotic Cell, 2014-05. Verfasst von Teraya M Donaldson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York, USA. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCRR NIH HHS, NIGMS NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intracellular pathogen Toxoplasma gondii is a purine auxotroph that relies on purine salvage for proliferation. We have optimized T. gondii purine nucleoside phosphorylase ( Tg PNP) stability and crystallized Tg PNP with phosphate and immucillin-H, a transition-state analogue that has high affinity for the enzyme. Immucillin-H bound to Tg PNP with a dissociation constant of 370 pM, the highest affinity of 11 immucillins selected to probe the catalytic site. The specificity for transition-state analogues indicated an early dissociative transition state for Tg PNP. Compared to Plasmodium falciparum PNP, large substituents surrounding the 5′-hydroxyl group of inhibitors demonstrate reduced capacity for Tg PNP inhibition. Catalytic discrimination against large 5′ groups is consistent with the inability of Tg PNP to catalyze the phosphorolysis of 5′-methylthioinosine to hypoxanthine. In contrast to mammalian PNP, the 2′-hydroxyl group is crucial for inhibitor binding in the catalytic site of Tg PNP. This first crystal structure of TgPNP describes the basis for discrimination against 5′-methylthioinosine and similarly 5′-hydroxy-substituted immucillins; structural differences reflect the unique adaptations of purine salvage pathways of Apicomplexa .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CatalysisCatalytic DomainCrystallography, X-RayEnzyme InhibitorsKineticsProtozoan ProteinsPurine NucleosidesPurine-Nucleoside PhosphorylasePyrimidinonesSubstrate SpecificityToxoplasma

Substanzen

Enzyme InhibitorsProtozoan ProteinsPurine NucleosidesPyrimidinonesforodesinePurine-Nucleoside Phosphorylase

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York, USA.

Förderung

  • NCRR NIH HHS
  • NIGMS NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Donaldson, T. M., Cassera, M. B., Ho, M. C., Zhan, C., Merino, E. F., Evans, G. B., Tyler, P. C., Almo, S. C., Schramm, V. L., & Kim, K. (2014). Inhibition and Structure of Toxoplasma gondii Purine Nucleoside Phosphorylase. Eukaryotic Cell, 13(5), 572-579. https://doi.org/10.1128/ec.00308-13

Vancouver

Donaldson TM, Cassera MB, Ho MC, Zhan C, Merino EF, Evans GB, et al. Inhibition and Structure of Toxoplasma gondii Purine Nucleoside Phosphorylase. Eukaryotic Cell. 2014;13(5):572-579. doi:10.1128/ec.00308-13

BibTeX
@article{Donaldson2014,
  author = {Donaldson, Teraya M and Cassera, María B and Ho, Meng-Chiao and Zhan, Chenyang and Merino, Emilio F and Evans, Gary B and Tyler, Peter C and Almo, Steven C and Schramm, Vern L and Kim, Kami},
  title = {Inhibition and Structure of Toxoplasma gondii Purine Nucleoside Phosphorylase},
  journal = {Eukaryotic Cell},
  year = {2014},
  volume = {13},
  number = {5},
  pages = {572--579},
  doi = {10.1128/ec.00308-13}
}
Kostenlos starten →